An injectable Cu-induced hydrogel with anti-PD-L1 and nitric oxide (NO) enhances immunotherapy by amplifying immunogenic cell death and limiting cancer-associated fibroblasts (CAFs), which impedes immune cell infiltration as well (Shen et al., 2023). This evidence concerns the gene CD274 and cancer.